These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28667476)

  • 1. 3D Homology Model of Sigma1 Receptor.
    Laurini E; Marson D; Fermeglia M; Pricl S
    Handb Exp Pharmacol; 2017; 244():27-50. PubMed ID: 28667476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the σ1 receptor and its ligand binding site.
    Brune S; Pricl S; Wünsch B
    J Med Chem; 2013 Dec; 56(24):9809-19. PubMed ID: 23964901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Another brick in the wall. Validation of the σ1 receptor 3D model by computer-assisted design, synthesis, and activity of new σ1 ligands.
    Laurini E; Marson D; Dal Col V; Fermeglia M; Mamolo MG; Zampieri D; Vio L; Pricl S
    Mol Pharm; 2012 Nov; 9(11):3107-26. PubMed ID: 23020867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Insights into Sigma1 Function.
    Kruse A
    Handb Exp Pharmacol; 2017; 244():13-25. PubMed ID: 27995388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sigma enigma: in vitro/in silico site-directed mutagenesis studies unveil σ1 receptor ligand binding.
    Brune S; Schepmann D; Klempnauer KH; Marson D; Dal Col V; Laurini E; Fermeglia M; Wünsch B; Pricl S
    Biochemistry; 2014 May; 53(18):2993-3003. PubMed ID: 24766040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal Chemistry of σ
    Weber F; Wünsch B
    Handb Exp Pharmacol; 2017; 244():51-79. PubMed ID: 28620761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor.
    Laurini E; Col VD; Mamolo MG; Zampieri D; Posocco P; Fermeglia M; Vio L; Pricl S
    ACS Med Chem Lett; 2011 Nov; 2(11):834-9. PubMed ID: 24900272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pd-catalyzed direct C-H bond functionalization of spirocyclic σ1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of the σ1 receptor.
    Meyer C; Schepmann D; Yanagisawa S; Yamaguchi J; Dal Col V; Laurini E; Itami K; Pricl S; Wünsch B
    J Med Chem; 2012 Sep; 55(18):8047-65. PubMed ID: 22913577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5D-QSAR for spirocyclic sigma1 receptor ligands by Quasar receptor surface modeling.
    Oberdorf C; Schmidt TJ; Wünsch B
    Eur J Med Chem; 2010 Jul; 45(7):3116-24. PubMed ID: 20427100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR and docking studies of pentacycloundecylamines at the sigma-1 (σ1) receptor.
    Geldenhuys WJ; Novotny N; Malan SF; Van der Schyf CJ
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1707-11. PubMed ID: 23414839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction to Sigma Proteins: Evolution of the Concept of Sigma Receptors.
    Kim FJ
    Handb Exp Pharmacol; 2017; 244():1-11. PubMed ID: 28871306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, pharmacological evaluation and binding mode analysis of novel chromene and chromane based σ1 receptor ligands.
    Laurini E; Harel D; Marson D; Schepmann D; Schmidt TJ; Pricl S; Wünsch B
    Eur J Med Chem; 2014 Aug; 83():526-33. PubMed ID: 24996139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of fenpropimorph as a σ receptor ligand: Structure-affinity relationship studies at human σ
    Sguazzini E; Schmidt HR; Iyer KA; Kruse AC; Dukat M
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2912-2919. PubMed ID: 28495085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands.
    Zampieri D; Vio L; Fermeglia M; Pricl S; Wünsch B; Schepmann D; Romano M; Mamolo MG; Laurini E
    Eur J Med Chem; 2016 Oct; 121():712-726. PubMed ID: 27366902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ
    Kopp N; Civenni G; Marson D; Laurini E; Pricl S; Catapano CV; Humpf HU; Almansa C; Nieto FR; Schepmann D; Wünsch B
    Eur J Med Chem; 2021 Jul; 219():113443. PubMed ID: 33901806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore models and development of spirocyclic ligands for σ1 receptors.
    Wunsch B
    Curr Pharm Des; 2012; 18(7):930-7. PubMed ID: 22288413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. σ
    Kim FJ; Pasternak GW
    Nat Struct Mol Biol; 2018 Nov; 25(11):992-993. PubMed ID: 30310147
    [No Abstract]   [Full Text] [Related]  

  • 18. High-affinity sigma-1 (σ
    Niso M; Mosier PD; Marottoli R; Ferorelli S; Cassano G; Gasparre G; Leopoldo M; Berardi F; Abate C
    Future Med Chem; 2019 Oct; 11(19):2547-2562. PubMed ID: 31633399
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands.
    Peng Y; Dong H; Welsh WJ
    J Chem Inf Model; 2019 Jan; 59(1):486-497. PubMed ID: 30497261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for σ
    Schmidt HR; Betz RM; Dror RO; Kruse AC
    Nat Struct Mol Biol; 2018 Oct; 25(10):981-987. PubMed ID: 30291362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.